Question 1

What is the catalog number for Compound NP-012106?

Accepted Answer

The catalog number for Compound NP-012106 is T130050.

Question 2

Is Compound NP-012106 in stock?

Accepted Answer

Compound NP-012106 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

Who manufactures Compound NP-012106?

Accepted Answer

Compound NP-012106 is manufactured by Molfinity.

Question 4

What is the estimated delivery time for Compound NP-012106?

Accepted Answer

Estimated delivery time for Compound NP-012106 is approximately 10 business day(s), depending on your location.

Question 5

Is this product tested for endotoxin levels?

Accepted Answer

Endotoxin testing status is noted on the datasheet where applicable, particularly for recombinant proteins intended for cell-based or functional assays. If this isn’t listed and you need confirmation, contact support with the catalogue number.

Question 6

Can I request additional validation data, such as western blot images, for this product?

Accepted Answer

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

Question 7

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Compound NP-012106

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

CIITA Human Gene Knockout Kit (CRISPR)

Tissue FFPE Sections, Bone: femur, distal

Benzhydryl 2-(3-benzyl-7-oxo-4-thia-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl)-3-morpholinobut-2-enoate (E/Z mixture)

SMAD4 (Pancreatic Adenocarcinoma Marker) (SMAD4/2524), CF640R conjugate, 0.1mg/mL

Tris-(2-chloroethyl)urea

Frozen Tissue Sections, Lung